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Interaction with Telencephalin
and the Amyloid Precursor Protein
Predicts a Ring Structure for Presenilins
several functional domains and regulates multiple sig-
naling pathways (De Strooper and Annaert, 2001).
PSs are endoproteolysed yielding saturable and sta-
ble complexes of N-terminal and C-terminal fragments
(NTF and CTF) (Thinakaran et al., 1996, 1997; Kim et al.,
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Flanders Interuniversity Institute for Biotechnology 1997). Moreover, intramolecular interactions between
both fragments are required for their normal biologicalKUL-Gasthuisberg
B-3000 Leuven function (Saura et al., 1999; Tomita et al., 1998). On the
other hand, the hydrophilic N terminus and the loopBelgium
domain of PS are dispensable for the endoproteolytic
activation, stabilization, and -secretase activity (Saura
et al., 2000; Tomita et al., 1998, 1999), and thereforeSummary
proteins interacting with these domains are probably not
directly involved in these proteolytic events. MutationalThe carboxyl terminus of presenilin 1 and 2 (PS1 and
analysis has furthermore shown that the C terminus ofPS2) binds to the neuron-specific cell adhesion mole-
PS is needed for stabilization, endoproteolysis, andcule telencephalin (TLN) in the brain. PS1 deficiency
A42 overproduction caused by FAD-linked mutationsresults in the abnormal accumulation of TLN in a yet
(Thinakaran et al., 1997; Tomita et al., 1999, 2001). Thisunidentified intracellular compartment. The first trans-
suggests strongly that the C terminus could mediatemembrane domain and carboxyl terminus of PS1 form
protein interactions critical for -secretase function.a binding pocket with the transmembrane domain of
This hypothesis was tested using the eight C-terminalTLN. Remarkably, APP binds to the same regions via
amino acids of PS1 as bait to screen a hippocampalpart of its transmembrane domain encompassing the
library by a yeast two-hybrid approach.critical residues mutated in familial Alzheimer’s dis-
We identified a specific interaction of the type I proteinease. Our data surprisingly indicate a spatial dissocia-
telencephalin (TLN) with PS1 and PS2. TLN (or ICAM-5)tion between the binding site and the proposed cata-
is a neuron- and region-specific member of the ICAMlytic site near the critical aspartates in PSs. They
subfamily of intercellular adhesion molecules (ICAM)provide important experimental evidence to support
(Gahmberg, 1997; Yoshihara and Mori, 1994). TLN pro-a ring structure model for PS.
motes dendritic outgrowth (Tian et al., 2000b) and con-
tributes to long-term potentiation (LTP) (Nakamura et
Introduction al., 2001). We analyzed the functional consequences of
disrupting the PS1-TLN interaction in neurons devoid
Presenilin 1 and 2 (PS1 and PS2) are homologous pro- of PS1. Delineating the binding sites in PS1, TLN, and
teins implicated in familial Alzheimer’s disease (FAD) APP allowed us to integrate our findings in a ring struc-
(Levy-Lahad et al., 1995; Rogaev et al., 1995; Sherring- ture model for PSs.
ton et al., 1995). FAD mutations in PSs increase the
secretion of the amyloidogenic A42 peptide, a major Results
constituent of the plaques in brains of AD patients (Cit-
ron et al., 1997; Duff et al., 1996; Scheuner et al., 1996). TLN Interacts with PS1 In Vitro and In Vivo
A42 and the more abundant A40 are generated from Two-hybrid screening of an unamplified mouse hippo-
the amyloid precursor protein (APP) by the consecutive campal library with the C-terminal eight amino acids of
action of - and -secretase (De Strooper and Annaert, PS1 identified a cDNA encoding the 256 C-terminal
2000; Haass and Selkoe, 1993; Selkoe, 1998). PSs are amino acids of TLN (TLN/256C). TLN (or ICAM-5) is a
part of the -secretase multiprotein complex, and it is neuron-specific type I membrane glycoprotein with
possible that they bear the catalytic site of the protease short cytoplasmic domain and nine tandem Ig-like do-
(reviewed in Esler and Wolfe, 2001; Sisodia et al., 2001; mains in the ectodomain, the two most distal domains
Steiner and Haass, 2000). Not only APP but also Notch being included in TLN/256C (Figure 1A).
is a target for PS-mediated regulated intramembrane Endogenous TLN could be precipitated from Triton
proteolysis (De Strooper et al., 1999; Struhl and X-100 brain extracts in a salt-dependent manner using
Greenwald, 1999). PSs are thus molecular switches be- immobilized GST proteins fused to the 39 C-terminal
tween proteolysis and cell signaling (Annaert and De residues of PS1 or PS2 (PS1/39C) (Figure 1B). Maximal
Strooper, 1999; Brown et al., 2000). The complexity of binding was observed below 150 mM NaCl. The lack of
PS function is illustrated even more by the experiments ER-resident proteins or synaptic vesicle proteins in the
of Soriano et al. (2001) demonstrating that PS1 is a precipitate demonstrates the specificity of the inter-
negative regulator of the Wnt/-catenin pathway. As action (Figure 1C). We detected a weak signal for en-
-catenin binding to PS1 is independent of -secretase dogenous holo-APP after long exposure. The reciprocal
function (Saura et al., 2000), it follows that PS1 contains experiment using GST-TLN/256C confirmed that endog-
enous PS1-CTF binds to TLN in a salt-dependent way
(Figure 1D). Although the PS1-NTF/CTF complex is Tri-1Correspondence: ad@med.kuleuven.ac.be
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Figure 1. TLN Binds PS1 In Vitro and In Vivo
(A) Structure of TLN with nine Ig-like domains (I to IX). TLN/256C identifies the fragment isolated by two-hybrid. The epitopes recognized by
pabs B35.1 and B36.1 are indicated.
(B) Endogenous TLN binds to GST-PS1/39C and -PS2/39C fusion proteins. Equal amounts of fusion proteins were incubated with low salt
Triton X-100 brain extracts (left) or in the presence of increasing salt concentrations (right, only for PS1/39C). Bound material was separated
on 12% NuPAGE, blotted, and probed with anti-TLN pab B36.1 (1/10,000).
(C) The PS1-TLN interaction is specific. GST-PS1/39C or GST alone was incubated with () or without () Triton X-100 brain extracts at low
(75 mM) or high (400 mM) salt concentration and the bound material (“beads”) was analyzed. Endogenous TLN was quantitatively retained
on the immobilized GST-PS1/39C at 75 mM NaCl (compare with depleted TLN signal in the unbound fraction [sup, 75 mM, one-third of the
input]). Except for some APP, other proteins such as synaptophysin, syntaxin, or synaptobrevin II, or ER-specific proteins (calnexin/PDI) did
not interact.
(D) GST-TLN/256C interacts with endogenous PS1. Immobilized GST-TLN/256C or GST was incubated with high or low salt, 1% Triton X-100
or 2% CHAPS brain extracts. PS1-CTF was predominantly detected in the bound fraction of low salt 1% Triton X-100 extracts. In the case
of 2% CHAPS, both the PS1-NTF and PS1-CTF were bound to GST-TLN/256C. The difference in intensity of the bands is due to different
affinities of the pabs as shown in “Total.” Binding was largely inhibited at 400 mM. Some endogenous APP was recovered on the beads,
especially from 2% CHAPS brain extracts. No binding was observed for synaptobrevin II and BAP31.
(E) Endogenous TLN and PS1 fragments coimmunoprecipitate. 1% Triton X-100 mouse brain extracts (1.5 mg/ml) were incubated overnight
with protein G Sepharose (15 l) and affinity purified B19.2 (anti-PS1-NTF) or B32.1 (anti-PS1-CTF). 2% of the extract (Total) and the unbound
supernatants, and total bound proteins were separated on 4%–12% NuPAGE followed by blotting. Incubations without extract or antibody
were used as negative controls. Antibodies to the transferrin receptor (TFR) were used to illustrate the specificity of the immunoprecipitation.
ton X-100 sensitive, minor amounts of PS1-NTF were from mouse brain Triton X-100 extracts. As shown in
Figure 1E, TLN significantly coprecipitated with PS1-detected in precipitates of Triton X-100-extracted mem-
branes, suggesting that TLN also interacted with the NTF or PS1-CTF. A control membrane protein, the trans-
ferrin receptor, did not. The coprecipitation of TLN withPS1-NTF. In the presence of 2% CHAPS, both PS1-NTF
and PS1-CTF were stochiometrically recovered on the PS1 was again salt dependent. It should be noted that
only a few percent of total TLN was recovered in thebeads, as both fragments remain associated under
these conditions (Capell et al., 1998). Apparently the bound fractions.
binding of the PS complex to GST-TLN/256C in CHAPS
is less efficient than the binding of PS1-CTF alone in TLN Does Not Colocalize with PS1
under Steady-State ConditionsTriton X-100. Since CHAPS is less denaturing than Triton
X-100, it is possible that the integrity of the complex TLN is a cell adhesion protein exclusively expressed
in neurons of the telencephalon (Benson et al., 1998;causes steric hindrance under these conditions (Capell
et al., 1998). The weak binding with APP could reflect Yoshihara et al., 1994). We therefore focused on the
analysis of endogenous TLN in primary hippocampalthe association of APP with PS1 in high molecular weight
complexes rather than a direct binding to GST-TLN/ neurons. TLN specifically localized to the somatoden-
dritic plasma membrane, while Tau-positive axons re-256C. Several other controls demonstrate again the
specificity of the PS1-TLN interaction (Figure 1D). mained negative (Figure 2A). TLN displays a characteris-
tic reticular staining pattern in horizontal sections andNext we tested whether this binding also occurs at
the endogenous level of expression. We immobilized presents as focal contacts when viewed laterally (Figure
2A), in accordance with its role in neurite outgrowthaffinity-purified pabs against either the PS1-NTF (B19.2)
or PS1-CTF (B32.1) and precipitated quantitatively PS1 and cell-cell interactions. Little or no colocalization was
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TLN was expressed in the PS1/ than in wild-type
neurons.
Since TLN accumulations were mainly seen near the
cell surface, we looked at the distribution of actin fila-
ments using phalloidin staining. Only in PS1/ neurons,
intense clusters of phalloidin staining, intimately associ-
ated with the TLN accumulations, were observed (Fig-
ures 3D and 3E). This suggests that the accumulating
TLN causes a local distortion of the actin cytoskeleton.
Because cell surface biotinylation failed to label TLN
clusters (Figure 3F), we conclude that they are localized
in the cell.
PS1 Regulates TLN Protein Expression
during Differentiation
TLN is only detected after birth and rises rapidly to stable
levels within the next month (Yoshihara and Mori, 1994).
This increase occurs concomitantly with the neurite out-
Figure 2. Localization of Endogenous TLN in Hippocampal Neurons growth and the establishment of synaptic contacts. This
Double immunofluorescent staining of differentiated hippocampal developmental regulation is equally preserved in hippo-
neurons (15 days in culture) for TLN (green, pab B36.1) and Tau (red campal neurons in culture. These neurons go progres-
in [A], mab Tau-1) or PS1 (red in [B], mab 5.2). Alexa488- (TLN) and sively through five stages of development and display
Alexa546- (Tau and PS1) conjugated secondary antibodies were at stage 5 full axonal and dendritic compartmentaliza-
used for detection.
tion and synapse formation (Dotti et al., 1988). We found(A) TLN immunoreactivity is exclusively localized to the somatoden-
that at day 4 post plating (early stage 4) only a fractiondritic area and does not overlap with axonal Tau staining (arrow-
heads in [A]).The vertical section shows that TLN is restricted to the of the wild-type neurons expressed TLN (Figure 3G). At
plasma membrane (bottom and white line, middle panel). day 16, 90% of the neurons were TLN positive. In PS1/
(B) At high resolution, little if any colocalization of TLN and PS1 is cultures, in contrast, already 15% of the neurons dis-
observed (inset at the top displays an overview of the neuron). played TLN staining at day 4, and the maximum fre-
Vertical sections 1–4 demonstrate that, opposed to TLN, PS1 immu-
quency was already reached at 10 days. From this stagenostaining is mainly located intracellularly. Some PS1 immunostain-
on, TLN accumulations were detected (7% of the posi-ing tends to cluster near TLN-positive focal contacts (arrowheads).
Bar  5 m. tive cells), and this number increased up to one-third of
the PS1/ neurons at day 16.
PS1 deficiency thus clearly affects both the onset of
observed between TLN and PS1 (Figure 2B, sections expression and the localization of TLN, which demon-
1–4). Interestingly however, PS1-positive compartments, strates a functional link between both proteins. It could
probably ER (Annaert et al., 1999), tended to tether be that PS1, like for APP and Notch, affects the proteoly-
closely to TLN-positive focal contact sites (arrowheads sis of TLN. Little is known however about TLN mediated
in Figure 2B). The lack of a significant colocalization at signal transduction pathways or TLN ectodomain shed-
the endogenous level suggests that the TLN-PS1 inter- ding, the classical requisites of -secretase processing
action is transient and may occur temporarily in com- (Brown et al., 2000; Struhl and Adachi, 2000). Using a
partments encountered by both proteins. This is also in sensitive reporter assay (Herreman et al., 2000), we
agreement with the previous results demonstrating that could find so far no evidence for TLN intramembrane
only low amounts of TLN coprecipitate with PS1 frag- proteolysis (data not shown).
ments (Figure 1E).
The Transmembrane Domain of TLN Is Required
for Binding to PS1Aberrant Localization of TLN in PS1/
Hippocampal Neurons We generated a series of constructs encoding subdo-
mains of TLN/256C (Figure 4A), which were expressedPS1/ embryos die late in embryogenesis (Hartmann et
al., 1999; Shen et al., 1997; Wong et al., 1997). Their using in vitro transcription/translation in the presence
of [35S]methionine and assayed for binding to GST-PS1/hippocampal formation is, however, sufficiently devel-
oped at day E17 to allow the culture of primary hippo- 39C. Only fragments encompassing the transmembrane
region of TLN maintained efficient binding to PS1/39Ccampal neurons. No gross differences were observed
between mature wild-type and PS1/ neurons in terms (Figure 4B). However, since oligomerization of the intra-
cellular (IC) domain of TLN (Figure 4B) might interfereof neuronal polarization and differentiation, although this
remains to be studied in more detail. Surprisingly, how- with binding, a series of radiolabeled, C-terminal trun-
cated fragments of TLN/256C was assayed for bindingever, in fully polarized PS1/ neurons, TLN immunoreac-
tivity accumulated in large clusters that are organized as well (Figure 4C). Only the first seven fragments bound
to GST-PS1/39C. Further deleting residues Val-829 toin honeycomb structures near the cell surface (Figures
3A and 3B and sections 1–4). These clusters reacted Trp-833 (fragment 8) compromised the binding indicat-
ing the importance of the N-terminal part of the trans-with N- and C-terminal specific antibodies indicating
that full-length TLN accumulated (Figure 3C). The overall membrane domain for PS1 interaction. The fact that
fragment 7 (Figure 4C) already shows a decreased bind-higher fluorescence intensity indicated finally that more
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ing suggests, in addition, that other parts of the trans-
membrane region contribute to the binding as well. The
importance of the transmembrane domain in PS1 inter-
action was further corroborated in primary neurons by
expressing TLN constructs with either a deleted ecto-
or cytoplasmic domain (TLNE and TLNCYT, respec-
tively). Both TLN fragments coimmunoprecipitated with
endogenous PS1 fragments (Figure 4D). It should be
noted that TLNE oligomerizes without interfering with
the binding to PS1.
The C-Terminal Part of the APP Transmembrane
Domain Binds to PS1
Others have shown that APP/C99, the direct substrate
for -secretase, can bind to PS1 (Verdile et al., 2000;
Xia et al., 2000). Based on the TLN data, we hypothe-
sized that the transmembrane domain of APP was in-
volved in this interaction. The -, -, and 40-cleaved
APP-CTFs (APP/C99, C83, and C59, respectively) were
expressed in wild-type neuron cultures (Figure 5A). All
three fragments specifically bound to GST-PS1/39C, but
not to GST-PS1/1-81N. The PS binding region must
therefore be located distally to the 40 cleavage site. A
series of C-terminal truncated APP/C99 constructs was
then tested for binding to GST-PS1/39C (Figure 5B).
While the cytoplasmic domain could be deleted, further
removal of 11 amino acids of the transmembrane do-
main (i.e., till the 42 cleavage site) abolished binding
to GST-PS1/39C (Figure 5B). Likewise, in vivo, overex-
pressed APP/C59 and APPCYT but not APP ectodo-
main fragments specifically coimmunoprecipitated with
PS1 in Triton X-100 neuronal extracts (Figure 5C). The
only common fragment is again the transmembrane re-
gion downstream of the 40 cleavage site. This hy-
drophobic stretch (Thr-639–Lys-649, numbering as in
APP695) is therefore essential for binding to PS1. Impor-
tantly, this short region encompasses the region con-
taining the FAD-causing mutations that affect -secre-
tase cleavage of APP.
Delineation of the TLN and APP Binding
Domains in PS1
We noticed in our initial experiments that, apart from
PS1-CTF, some PS1-NTF also bound to TLN, even in
the presence of Triton X-100 (Figure 1E). To analyze
which subdomains of PS1 could bind to TLN, a series
of PS1 fragments (Figure 6A) were fused to GST andFigure 3. TLN Accumulates in Mature PS1/ Hippocampal Neurons
tested in our binding assay. All fusion proteins that con-(A and B) Three-dimensional reconstitution of the distribution of
tained the C-terminal 39 amino acids of PS1 displayedendogenous TLN in differentiated hippocampal neurons (15 days
culture) from wild-type (A) and PS1/ (B) embryos. Each picture is
composed of 35 confocal sections (to be viewed with 3D specta-
cles). Only in PS1/ neurons, TLN immunostaining is recovered in
large accumulations close to the cell surface (sections 1–4) in addi- prior to fixation, permeabilization, and incubation with anti-TLN
tion to the plasma membrane labeling. (B36.1). Biotin, visualized by streptavidin-Texas red, colocalized
(C) Double immunofluorescent staining for endogenous TLN accu- with TLN only at the cell surface and not with TLN accumulations,
mulations in PS1/ neurons using antibodies directed against the indicating that they are localized intracellularly. Bar  5 m.
C terminus (TLN-C, B36.1) and the N terminus (TLN-N, mab TLN-3 (G) Time course of TLN protein expression in developing hippocam-
[Tian et al., 2000a]). Both antibodies immunolabel the same TLN pal neurons. Neurons from PS1/ and wild-type littermates were
accumulations. grown for 4, 7, 10, and 16 days, fixed, and immunostained for TLN.
(D and E) Double fluorescent labeling for TLN and actin, visualized The ordinate gives the percentage of neurons expressing TLN at
by Texas red-phalloidin (PHAL). Colocalization was observed with each time point. The number of TLN-positive neurons increases
TLN accumulations (see vertical section in [E]), while the fine periph- more rapidly in PS1/. TLN accumulations were first noticed at day
eral phalloidin-positive punctae did not codistribute with TLN. Arrow 10 but became much more frequent at day 16. Results are shown
in (D) indicates the position of the vertical section in (E). for four independent experiments with 500–1200 neurons for each
(F) Cell surface biotinylation. Intact PS1/ neurons were biotinylated time point (mean 	 SEM).
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specific binding to TLN as expected (Figure 6B). In addi-
tion, however, GST-PS1/1-163N (i.e., the PS1 N-terminal
domain including the first two transmembrane regions)
could also bind TLN. Further downsizing of this fragment
showed that the first, but not the second, transmem-
brane domain is needed for binding (Figure 6B). Thus,
both the C-terminal tail and the first transmembrane
domain (Val-82–Ser-102) and possibly part of the first
luminal loop domain of PS1 constitute binding sites for
TLN.
Interestingly, radiolabeled APP/C99 was recovered on
exactly the same recombinant GST-PS1 fragments as
TLN (Figure 6C), corroborating our conclusion that APP
and TLN bind to very similar sites in PS1.
Discussion
The Interaction between TLN and PS1 Occurs
Transiently and Is Important for TLN Localization
Using four independent in vitro and in vivo approaches,
compelling evidence was obtained that TLN binds to
PS1 and PS2. Importantly, the interaction was also es-
tablished at the endogenous level of expression. It is
clear, however, that only a small fraction of TLN binds
PS1 under steady-state conditions (Figure 1E), indicat-
ing that the interaction is functional and not structural.
This was further corroborated using confocal micros-
copy. We confirm that PS1 is mainly restricted to pre- Figure 4. PS1 Binds to the Transmembrane Domain of TLN
Golgi compartments in cultured neuronal cells (Annaert (A) Scheme of the N- or C-terminal truncated mutants of TLN/256C
generated by in vitro transcription/translation and assayed for bind-et al., 1999; Culvenor et al., 1997; Kim et al., 2000), while
ing to GST, GST-PS1/39C, or GST-PS1/1-81N (Coomassie stainedTLN resides almost exclusively at the somatodendritic
bands in bottom panel).plasma membrane. Occasionally, some PS1-positive
(B) Total: autoradiogram of [35S]methionine-labeled TLN fragments.membranes closely juxtaposed to TLN positive patches Similar amounts of input material were used. Note the oligomerized
were observed, probably at the level of focal contacts. nature of the intracellular domain (IC). Only TLN/256C and the mu-
On the other hand, PS1 deficiency caused striking alter- tants that encompass the transmembrane domain (TMR) bind effi-
ciently to immobilized GST-PS/39C but not GST or GST-PS1/1-81N.ations in the subcellular distribution of endogenous TLN,
EC, ectodomain.which became missorted and accumulated in large in-
(C) Mapping of the binding domain of TLN.C-terminal truncatedtracellular structures. This provides very strong evi-
TLN/256C mutants (top) were generated by in vitro transcription/dence that the biochemical interaction is indeed physio- translation (Total) and were assayed for binding to GST-PS1/39C
logically relevant. Further analysis showed that TLN, a or GST- PS1/1-81N. Binding is virtually abolished when the N-termi-
strongly developmentally regulated protein (Benson et nal five amino acids (Val-829–Trp-833) of the transmembrane region
of TLN are deleted (fragment 8).al., 1998), is detected significantly earlier in PS1/ neu-
(D) Overexpressed mutant TLN lacking the ectodomain (TLNE, top)rons than in their wild-type counterparts. Also, the rela-
or the cytoplasmic domain (TLNCYT, bottom) coimmunoprecipi-tive numbers of neurons expressing TLN at the cell sur-
tate with endogenous PS1 fragments. Both TLN mutants were over-face increases more rapidly in the absence of PS1. expressed in primary neurons. Low salt 1% Triton X-100 extracts
Furthermore, as TLN accumulations are only seen in were incubated with affinity-purified anti-PS1-NTF (B19.2) or -CTF
differentiated PS1/ neurons and not at early stages, (B32.1), and the bound fraction was analyzed by Western blotting
using biotinylated B36.1 or B35.1 followed by streptavidin-HRP tothey apparently reflect a time-related cumulative effect
detect TLNE and TLNCYT, respectively. TLNE and TLNCYTof PS1 deficiency. This can easily be interpreted in a
were selectively recovered in the bound fraction while PDI, syntaxin,context of a defective functional PS1-TLN interaction,
and synaptobrevin II (sybII) were not. Note that TLNE fragmentseven if only small quantities of TLN interact with PS1 at form tetramers (asterisk indicates nonspecific bands; PI, preimmune
any given point in time. We obtained some evidence serum).
that the normal turnover of TLN is affected in PS1/
neurons, not unlike what has been observed before with
-catenin in PS1 knockout cells (Soriano et al., 2001). also implicated in neurite outgrowth and branching (Be-
rezovska et al., 1999; Sestan et al., 1999), it follows thatThis possibility is currently investigated in more detail.
Interestingly, TLN accumulates in intracellular struc- PS1 apparently controls at least two pathways involved
in neuritic arborization. It is therefore surprising thattures and seems to cause a local reorganization of the
subcortical actin cytoskeleton (Figures 3D–3F). Tian et the absence of PS1 has so little effect on the overall
morphology of mature neurons in culture (this study).al. (2000b) have demonstrated a link between the actin
cytoskeleton and TLN. This interaction is important for We conclude that important compensating mechanisms
must be at work and anticipate more subtle, yet-to-beintercellular adhesion believed to control neurite out-
growth in the telencephalon. Since Notch signaling is discovered physiological alterations in neuritic out-
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Figure 5. Mapping the PS1 Binding Domain
in APP/C99
(A) APP-CTFs interact with GST-PS1/39C.
cDNA constructs encoding the APP-CTFs
generated by-, -, and 40-secretase cleav-
age (APP/C99, /C83, and /C59) were cloned
in pSFV and transfected in primary neurons
in the presence of [35S]methionine. Low salt
1% Triton X-100 extracts were incubated with
immobilized GST-PS1/39C (right, top) and
GST-PS1/1-81N (right, bottom). All three APP
stubs interact solely with GST-PS1/39C.
(B) Top: C-terminal truncated fragments of
APP/C99 used for in vitro transcription/trans-
lation. 35S-labeled protein fragments were in-
cubated with the indicated fusion proteins.
Binding to GST-PS1/39C is observed with the
first four constructs, demonstrating that the
cytoplasmic tail of APP is not required for
interaction. Deleting the 11 amino acids
downstream of the 40 cleavage site abol-
ished binding.
(C) The APP transmembrane region is re-
quired for PS1 interaction in vivo. APP/C59
(top) and APPCYT (middle) were expressed
in neurons, and low salt 1% Triton X-100 ex-
tracts were subjected to immunoprecipitation
using pabs to PS1 fragments (as in Figure 4D).
Both APP fragments coimmunoprecipitated
with endogenous PS1 fragments. Bottom: overexpressed APP ectodomain fragments, APP626stop and APPstop, did not coimmunoprecipitate
with anti-PS1-CTF (B32.1) and -NTF (not shown). No binding was observed with preimmune serum (PI) or in the absence of overexpressed
protein (asterisk in middle panel points to endogenous APP). No PDI, syntaxin, or synaptobrevin II (sybII) was detected in the precipitate.
growth and/or synaptogenesis caused by the absence FAD-causing missense mutations in APP that shift the
-secretase cleavage toward A42 production are lo-of PS1. In line with this hypothesis are recent observa-
tions in PS1 conditionally targeted mice. These mice do cated within this short sequence (Selkoe, 1998, and
http://molgen-www.uia.ac.be/ADMutations). It seemsnot show abnormalities in the Notch signaling pathway,
but nevertheless display subtle cognitive deficits (Yu et likely that the FAD mutations may affect the binding of
APP with PS1 and that, by doing so, they modulate theal., 2001). Whether accumulation of TLN can explain this
phenotype is an interesting possibility. It is to be noted presentation of APP to -secretase. Therefore, small
compounds mimicking the binding sites in APP or inthat mice lacking TLN display also no abnormalities
apart from changes in hippocampal LTP (Nakamura et TLN, or binding selectively to the APP and not the TLN
sequence, could possibly prevent the processing of APPal., 2001).
by -secretase.
PS1 Binds to the Transmembrane Domain
of APP and TLN Molecular Delineation of a Binding Pocket in PS1
TLN was identified via two-hybrid screening using theWe demonstrate that the interaction of TLN with the C
terminus of PS1 requires at least five amino acids (Val- C-terminal eight amino acids of PS1 as a bait. Residues
Leu-460 to Ile-467 in PS1 thus define the minimal binding829–Trp-833) in the N-terminal part of the transmem-
brane region. This suggests that the hydrophobic PS1 region with TLN. In further experiments, we found that
the interaction is more efficient when the whole C termi-C terminus can intrude into the lipid bilayer to interact
with this part of the TLN transmembrane domain. Also nus of PS1 (or PS2) is used (Lys-429–Ile-467, and the
corresponding sequence in PS2), which is not unex-for APP, the PS1 binding site is in the transmembrane
domain, but located in the 11 amino acids (Thr-639–Lys- pected since the structure of a peptide in a protein is
strongly influenced by neighboring sequences. Impor-649) situated at its C-terminal end. This extends previous
work demonstrating that the cytoplasmic domain of APP tantly, when we scanned the PS1 protein for additional
binding sites, we established that the first transmem-(Xia et al., 1997) and large parts of the ectodomain are
not needed for PS1 binding (Verdile et al., 2000; Xia et brane region of PS1 (Val-82–Ser-102) determined a sec-
ond important binding site for TLN and APP. Two do-al., 2000). We speculate that the binding region is crucial
for the presentation of APP to the catalytic domain of mains at opposing sites in the PS1 sequence are
therefore apparently involved in TLN and APP binding.-secretase. In support of this conclusion, phenylala-
nine-scanning mutagenesis of this region (Lichtenthaler Coimmunoprecipitation of Notch with the PS1-NTF as
well as with the PS1-CTF has also been demonstratedet al., 1999) influenced significantly -secretase pro-
cessing of APP. Also peptidomimetics that inhibit the (Ray et al., 1999), although the exact binding sites were
not identified. Our results suggest that certain type I42 cleavage of APP include amino acids of this region
(Wolfe et al., 1998, 1999). Most importantly, all known membrane proteins bind via their transmembrane do-
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Figure 7. A Ring Structure Topology for PS1
(A) Eight transmembrane topology of the heterodimeric PS1 frag-
ments as proposed by Doan et al. (1996) and Li and Greenwald
(1998). Gray bands in the transmembrane regions 6 and 7 indicate
the positions of the critical aspartate residues believed to constitute
the catalytic site of PS1 (Esler and Wolfe, 2001). Yellow (first trans-
membrane region,Val-82–Ser-102, and the C-terminal domain, Lys-
429–Ile-467) delineates the critical domains involved in binding to
Figure 6. Delineation of Additional Binding Sites in PS1 TLN or APP (this study).
(A) Scheme of the different GST-PS1 fusion proteins. Numbers indi- (B) Proposed models for the binding of TLN (left) and APP/C99 to
cate the transmembrane regions, arrowhead points to the cleavage PS1. Since the PS1exon9 mutant does not need to be proteolyti-
site in PS1. cally cleaved to be active, both PS1-NTF and -CTF are depicted as
(B) Triton X-100 brain extracts were incubated with equal amounts associated. Our data show that both the first transmembrane do-
of the different fusion proteins and the bound material was analyzed main and the C terminus of PS1 are involved in the binding to TLN
for binding of TLN using pab B36.1. Strong binding was observed and APP (green segment in transmembrane region). This implies a
for all constructs that contained either the first transmembrane re- ring structure topology for PS1 bringing the interaction sites in close
gion or the 39 C-terminal amino acids of PS1. Some binding was apposition in a binding module. The model implies that the C termi-
observed with GST-PS1/102-163N, indicating that part of the first nus of PS1 can intrude into the lipid bilayer.
luminal loop domain may weakly contribute to the binding with TLN.
No binding was observed with the transferrin receptor (TFR).
(C) APP/C99 was expressed in primary cortical neurons in the pres-
these domains in the PS homologs of C. elegans (Ar-ence of [35S]methionine, and low salt 2% CHAPS extracts were
duengo et al., 1998; Levitan and Greenwald, 1995;incubated with the different fusion proteins. APP/C99 was equally
Okochi et al., 2000) and Drosophila (Lukinova et al.,expressed in all lanes (top) and bound to exactly the same PS1
fragments as TLN (bottom). Similar results were obtained when Tri- 1999) have been reported. If both domains comprise
ton X-100 was used. together a functional binding pocket, they should be
closely juxtaposed in the lipid bilayer, suggesting a cir-
cular or ring-like structure for PS1 (Figure 7B). Although
provocative, such a model supports recent findings that
main to a common binding pocket constituting the intramolecular associations between different domains
C-terminal domain and the first integral membrane do- of PS1, as well as cooperative interactions between both
main of PS1 (Figure 7A). We notice that our data are fragments, are important for the functionality of the PS
in conflict with Pradier et al. (1999) who identified the complex (Saura et al., 1999; Tomita et al., 1998). While
hydrophilic N terminus as the major site of interaction other, more complicated models could be envisaged,
with APP. We believe that this interaction is nonphysio- the fact that the PS1exon 9, as well as other mutations
logical since it was only observed when the N-terminal that prevent endoproteolysis of PS1, maintains -secre-
PS1 fragment was targeted to the ER lumen, while this tase cleavage of APP (Steiner et al., 1999a, 1999b) sup-
domain, under normal conditions, is oriented to the cyto- ports our model that both fragments remain closely as-
plasm (De Strooper et al., 1997; Doan et al., 1996; Li sociated in a ring-like structure. Our model implies the
and Greenwald, 1998). possibility that the hydrophobic C terminus of PS1 can
The fact that the binding domains in PS1 are excep- penetrate to different extents into the membrane, and
tionally well conserved among different species further we postulate a regulatory function for this part of PS1.
corroborates our hypothesis that they are of major func- Furthermore, our model suggests that the supposedly
tional importance. Consistently, only few disease-linked catalytic site in PS1 and the APP binding site are remote
mutations are found in these regions (Cruts and Van (Figure 7). This implies that binding and cleavage of
Broeckhoven, 1998; http://molgen-www.uia.ac.be/AD- substrate are two separate events. If PS1 is indeed the
-secretase, we have to assume that substrate presen-Mutations) while some loss-of-function mutations in
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coupled transcription-translation reaction (TnT system, Promega)tation to the catalytic domain near the aspartate resi-
in the presence of [35S]methionine. The reaction mixture was diluteddues involves a refolding of the PS1 binding module
40-fold in low-salt buffer (LSB: 75 mM NaCl, 10 mM Tris, 1 mMinto the interior of the ring structure. It is also possible
EDTA [pH 7.4]) containing 1% Triton X-100 or 2% CHAPS.
that PSs, after binding substrates like APP(-CTF), Notch,
or TLN, tag or transport these proteins for destination
Brain Extractsto a downstream compartment, like SCAP is doing for
Murine cortices (newborn or 1-month-old) were homogenized inSREBP to become cleaved by S1P (DeBose-Boyd et al.,
250 mM sucrose containing 10 mM Tris-HCl (pH 7.4), 1 mM EDTA (De1999). The missorting of TLN in PS1-deficient neurons
Strooper et al., 1999). After low-speed centrifugation, microsomal
is at least compatible with this possibility as well. membranes were collected by high-speed centrifugation (140 K gmax,
1 hr) and resuspended in LSB containing 1% Triton X-100 or 2%
CHAPS. Aliquots (1–1.5 mg/ml) of the cleared extracts (140 K gmax,Presenilin as Integrators of Several
1 hr) were incubated overnight (4
C) with immobilized GST fusionSignaling Pathways
proteins. Beads were washed in LSB containing 0.5% Triton X-100
To date, the type I membrane proteins shown to bind and analyzed by SDS-PAGE and Western blotting.
PS can be subdivided in three functional classes. APP
and Notch (Ray et al., 1999; Weidemann et al., 1997;
Viral ConstructsXia et al., 1997) are -secretase substrates, and their
pSFV-APP/C99, -APP/C83, -APP/C59, and -APPCYT have beenregulated intramembrane proteolysis depends critically
described (Cupers et al., 2001). pSFV constructs coding for the
on PSs (Esler and Wolfe, 2001; Selkoe, 2001; Sisodia et complete APP ectodomain (APP629stop) or the -secretase gener-
al., 2001; Steiner and Haass, 2000). Nicastrin (Yu et al., ated ectodomain (APPstop) were used as a control. New pSFV
2000) binds strongly to PSs, but appears to be a modula- constructs were generated encoding mouse TLN or mouse TLN
with a deleted ectodomain or cytoplasmic region (pSFV-TLNE andtor of and not a substrate for -secretase. Finally, cadh-
-TLNCYT, respectively). (See Annaert et al., 1999, and referenceserin (Georgakopoulos et al., 1999) and TLN are both cell
herein for further technical details concerning the use of SFV.)adhesion proteins, and PS1 may modulate their correct
cell membrane insertion and therefore their adhesive
functions at the cell membrane. PS1 regulates also to Indirect Immunofluorescence Microscopy
Hippocampal neurons were processed for immunofluorescence mi-a certain extent Wnt signaling via its interaction with
croscopy as described (Annaert et al., 1999) using Alexa488- and-catenin (Soriano et al., 2001).
Alexa546-conjugated secondary antibodies (1/1000, MolecularTherefore, the PSs are at the crossroads of several
Probes) for detection. Cell surface biotinylation was performed withimportant signaling pathways, and the question is now
sulfo-NHS-LC-biotin (Perbio) and detected with streptavidin-Texas
whether PSs are a means of cross-talk between these red. Actin filaments were visualized by phalloidin-Texas red (Molec-
pathways. By defining precisely the molecular domains ular Probes). Fluorescent stainings were captured through a Bio-
Rad MRC1024 confocal microscope and processed with Adobeinvolved in the interaction of PS1 with APP and TLN,
Photoshop 5.2 (Adobe, CA).we provide a structural basis for further investigations
of this question. It is also clear that these binding sites
provide novel potentially important targets for drug de- Antibodies
velopment in the fight against Alzheimer’s disease. Rabbit polyclonal antibodies (pabs) B35.1 and B36.1 (Figure 1A)
were raised using the synthetic peptides RGGLETSLRRNGTQRGLR
(in the first Ig-like domain of TLN) and GAEGGAETPGTAESPADGExperimental Procedures
(in the cytoplasmic region of TLN) coupled to KLH (Pierce). Pab
B17.2, B32.1, B19.2, and mab 5.2 against PS1 and B11.7 againstYeast Two-Hybrid and Vector Construction
the C terminus of APP have been described (Annaert et al., 1999;Mouse hippocampal mRNA was used to generate a primary  library
De Strooper et al., 1997). Monoclonal antibodies (mab) against sy-that was converted to a pAD-GAL4 plasmid library (HybriZAP, Stra-
naptobrevin II (clone 69.1), synaptophysin (clone 7.2), and syntaxintagene). The sequence coding for the PS1 8 C-terminal amino acids
I (clone 78.1) were provided by R. Jahn (MPI-Biophysical Chemis-was cloned into pBD-GAL4 vector (bait). Yeast transformed with
try,Go¨ttingen). Anti-PDI mab was from S. Fuller (EMBL, Heidelberg)bait and library (Gietz et al., 1995) was screened for His. Positive
and anti-TLN mab (TLN-3; Tian et al., 2000a) from C. Gahmbergcolonies were assayed for lacZ gene expression by the -galactosi-
(Helsinki, Finland). Pabs against calnexin, BAP31, and ERGIC-53dase filter lift assay. We isolated a cDNA encoding the C-terminal
were provided by A. Helenius (ETH-Zu¨rich, CH), M. Reth (MPI-Immu-256 amino acids of TLN (TLN/256C, Figure 1A).
nologie, Freibourg, DE) and J. Saraste (Univ. Bergen, Norway). Mab
against BIP and -COP were from Sigma and mab 22C11 and anti-
Production of Recombinant Proteins
Tau-1 from Boehringer.
cDNAs encoding TLN/256C, or various N- and C-terminal fragments
For coimmunoprecipitation, the B19.2, B32.1, B35.1, and B36.1
of PS1 were subcloned into pGEX4T-1 (Pharmacia) and transformed
sera were affinity purified using the peptide antigens cross-linked to
in E. coli BL21. GST fusion protein was induced with 0.1 mM IPTG
NHS-activated Sepharose 4FastFlow (Pharmacia BioTech). Affinity-
and released by sonicating the bacteria in Tris-saline buffer (150 mM
purified B35.1 and B36.1 were biotinylated (ECL-protein biotinyla-
NaCl with 10 mM Tris [pH 7.4]) containing 100 g/ml lysozyme, 5
tion module, Amersham) and used to detect coimmunoprecipitated
mM DTT, protease inhibitors, and 0.5% Sarcosyl (Frangioni and
endogenous TLN.
Neel, 1993). Triton X-100 (1% final) was added to the cleared extract,
and proteins were bound to Glutathione beads (Pharmacia).
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